VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
+55.69%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1.22B
AUM Growth
+$309M
(+34%)
Cap. Flow
+$126M
Cap. Flow
% of AUM
10.33%
Top 10 Holdings %
Top 10 Hldgs %
72.94%
Holding
57
New
4
Increased
7
Reduced
9
Closed
10
Top Buys
| 1 |
Soleno Therapeutics
SLNO
|
$210M |
| 2 |
Geron
GERN
|
$16.1M |
| 3 |
Tourmaline Bio
TRML
|
$15.5M |
| 4 |
SLN
Silence Therapeutics
SLN
|
$8.86M |
| 5 |
Pharvaris
PHVS
|
$7.99M |
Top Sells
| 1 |
SVA
Sinovac Biotech, Ltd
SVA
|
$38.2M |
| 2 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$32.5M |
| 3 |
Arcellx
ACLX
|
$18.1M |
| 4 |
Ventyx Biosciences
VTYX
|
$14.7M |
| 5 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
$13.4M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| 3 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Clene
CLNN
$60.2M
| – | – |
-132,267
| Closed | -$1.4M |
|
52
Fulcrum Therapeutics
FULC
$414M
| – | – |
-520,000
| Closed | -$2.31M |
|
|
53
Ventyx Biosciences
VTYX
$180M
| – | – |
-422,075
| Closed | -$14.7M |
|
|
ASLN
54
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| – | – |
-71,023
| Closed | -$1.07M |
|
|
IMPL
55
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| – | – |
-2,884,789
| Closed | -$1.24M |
|
|
AMRS
56
DELISTED
Amyris Inc.
AMRS
| – | – |
-7,750,828
| Closed | -$465K |
|
|
SVA
57
DELISTED
Sinovac Biotech, Ltd
SVA
| – | – |
-5,900,000
| Closed | -$38.2M |
|